Biography

David F. Rodriguez-Buritica, MD, is a board-certified pediatric endocrinologist and medical geneticist with a specialized focus on genetic and metabolic disorders affecting carbohydrate metabolism, and growth, bone, and sexual-development disorders. He earned his medical degree from the National University of Colombia in 1999 and completed his pediatrics residency and pediatric endocrinology fellowship at Winthrop University Hospital. He went on to complete a clinical genetics fellowship at the University of Alabama at Birmingham in 2014.

Dr. Rodriguez-Buritica holds dual board-certifications from the American Board of Pediatrics in Pediatric Endocrinology and the American Board of Medical Genetics and Genomics. His clinical and research interests span a broad range of genetic endocrine conditions, including glycogen storage disorders (GSD), Noonan syndrome, Turner syndrome, disorders of sexual development, skeletal dysplasias and X-linked hypophosphatemic (XLH) rickets. He is also engaged in advancing therapies in gene therapy and novel treatments for rare forms of short stature and bone metabolism disorders.

Dr. Rodriguez-Buritica is actively involved in clinical research, particularly focusing on the endocrinopathies associated with Tuberous Sclerosis Complex (TSC) and mitochondrial diseases. He has published and presented extensively and is recognized for his contributions to improving diagnostic and therapeutic strategies for complex pediatric endocrine and genetic disorders.

Education

Medical School
School of Medicine. National University of Colombia, Bogota, Colombia, 1999
Residency
Winthrop University Hospital, General Pediatrics Residency, Mineola, New York, 2006-2009
Fellowship
Winthrop University Hospital, Pediatric Endocrinology, Mineola, New York, 2009-2012
Fellowship
University of Alabama at Birmingham Clinical Genetics Fellowship, Birmingham, Alabama, 2012- 2014

Areas of Interest

Clinical Interests

Carbohydrate metabolism disorders including Glycogen Storage Disorders (GSD)

Genetics of growth disorders: Noonan syndrome and skeletal dysplasias

Sex chromosomal disorders: Turner syndrome and others

Genetics of disorders of sexual development

Disorders of bone metabolism: X-linked hypophosphatemic (XLH) rickets, other genetic forms of rickets and hypophosphatasia

Endocrinopathies associated to Tuberous Sclerosis complex (TSC) and mitochondrial disease

Gene therapy and other approaches for treatment of GSD

Novel therapies for genetic forms of short stature and disorders of bone metabolism